Evolution of In Vitro Antimicrobial Susceptibility of Equine Clinical Isolates in France between 2016 and 2019.
antibiotic resistance
epidemiology
horse pathogens
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
06
04
2020
revised:
30
04
2020
accepted:
06
05
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
13
5
2020
Statut:
epublish
Résumé
The present study described the evolution of antimicrobial resistance in equine pathogens isolated from 2016 to 2019. A collection of 7806 bacterial isolates were analysed for their in vitro antimicrobial susceptibility using the disk diffusion method. The most frequently isolated pathogens were group C Streptococci (27.0%), Escherichia coli (18.0%), Staphylococcus aureus (6.2%), Pseudomonas aeruginosa (3.4%), Klebsiella pneumoniae (2.3%) and Enterobacter spp. (2.1%). The majority of these pathogens were isolated from the genital tract (45.1%, n = 3522). With the implementation of two French national plans (named ECOANTIBIO 1 and 2) in 2012-2016 and 2017-2021, respectively, and a reduction in animal exposure to veterinary antibiotics, our study showed decreases in the resistance of group C Streptococci, Klebsiella pneumoniae and Escherichia coli against five classes, four classes and one class of antimicrobials tested, respectively. However, Staphylococcus aureus, Escherichia coli and Enterobacter spp. presented an increased resistance against all the tested classes, excepted for two fifths of E. coli. Moreover, the percentages of multi-drug resistant strains of Staphylococcus aureus and Enterobacter spp. also increased from 24.5% to 37.4% and from 26.3% to 51.7%, respectively. The data reported here are relevant to equine practitioners and will help to improve knowledge related to antimicrobial resistance in common equine pathogens.
Identifiants
pubmed: 32392891
pii: ani10050812
doi: 10.3390/ani10050812
pmc: PMC7278474
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Equine Vet J. 2020 Jan;52(1):112-119
pubmed: 31033041
J Equine Sci. 2012;23(2):17-26
pubmed: 24833992
Vet Microbiol. 2013 Mar 23;162(2-4):396-407
pubmed: 23146168
BMC Microbiol. 2017 May 3;17(1):104
pubmed: 28468636
Equine Vet J. 2017 Mar;49(2):146-148
pubmed: 28177154
J Glob Antimicrob Resist. 2019 Dec;19:144-153
pubmed: 30880244
Vet Microbiol. 2015 Aug 31;179(1-2):119-25
pubmed: 26123371
Equine Vet J. 2014 Mar;46(2):161-8
pubmed: 23808791
Antibiotics (Basel). 2017 Jun 06;6(2):
pubmed: 28587316
Can Vet J. 2016 Jul;57(7):747-51
pubmed: 27429463
Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):290-1
pubmed: 9707316
Vet Rec. 2016 Jan 23;178(4):91-2
pubmed: 26795860
Schweiz Arch Tierheilkd. 2016 Jun;158(6):433-42
pubmed: 27504838
Can Vet J. 2008 Feb;49(2):153-60
pubmed: 18309745
Int J Infect Dis. 2010 Sep;14 Suppl 3:e233-5
pubmed: 20004124
Vet Rec. 2015 Mar 28;176(13):334
pubmed: 25628448
BMC Microbiol. 2014 Jul 12;14:187
pubmed: 25014994
mBio. 2017 Aug 1;8(4):
pubmed: 28765219
J Vet Intern Med. 2018 Mar;32(2):633-647
pubmed: 29424487
J Am Vet Med Assoc. 2013 Apr 1;242(7):977-83
pubmed: 23517211
Prev Vet Med. 2017 Dec 1;148:37-43
pubmed: 29157372